Successful Migration to a Vancomycin AUC-dosing protocol: Evaluation, Implementation, and Outcomes in an Acute Care Hospital Setting

Thursday, June 9th, 2022 | 11:00 AM - 12:00 PM CT

The 2020 vancomycin revised consensus guidelines presented a major shift in how providers manage dosing. The drug, with a narrow therapeutic window, is easy to underdose or overdose.

During this webinar, experts will share how an acute care hospital successfully evaluated and implemented a vancomycin Bayesian dosing tool in compliance with the latest consensus guidelines. They will cover how the tool informs Area Under the Curve (AUC) target attainment, decreases toxicity and improves workflows. They will also review the benefits of Model Informed Precision Dosing and its role in the future of personalized medicine.

Key learning points:
  • Understand the benefits of Model Informed Precision Dosing, coupled with continuous learning, and how organizations can quickly improve workflow and outcomes
  • Learn key decision points in the evaluation of a Bayesian dosing solution
  • Glean clinical pearls in dosing more complicated patients
  • Examine the role of Model Informed Precision Dosing in various therapeutic categories 


Jon Faldasz - MB - Maddi Billings

Jon Faldasz, PharmD, BCPS

Senior Director of Product Experience, InsightRX

Craig Randall - MB - Maddi Billings

Craig Randall, PharmD

Antimicrobial Stewardship Manager, Wentworth-Douglass Hospital